Return To Sender, Industry Groups Say Of AER Address Guidance
This article was originally published in The Tan Sheet
Executive Summary
FDA's recommendation for complete addresses on OTC and dietary supplement product labels in order to comply with the adverse event reporting law exceeds not only Congress's intent, but also the requirements for all other products regulated by the agency, industry groups say